#CHRDL2
LightNews LightNews
cengem.bsky.social
We now have the audio summary of "#BMP antagonist #CHRDL2 enhances the #cancer #stemcell phenotype and increases #chemotherapy resistance in #colorectal cancer" by Eloise Clarkson and Annabelle Lewis published in Molecular Oncology
open.spotify.com/episode/3vv8...
E03 - CHRDL2 in Colorectal Cancer [New paper from Lewis Lab]
CenGEM | Centre for Genome Engineering and Maintenance · Episode
open.spotify.com
July 3, 2025 at 2:47 PM
rridrobot.bsky.social
RRIDs were included in this paper. RRIDs improve reproducibility in scientific research. #ReproducibleResearch #ReproducibleResearch #STMpublishing
BMP antagonist CHRDL2 enhances the cancer stem‐cell phenotype and increases chemotherapy resistance in colorectal cancer
doi.org
November 9, 2025 at 8:00 AM
biorxiv-cancer.bsky.social
BMP antagonist CHRDL2 enhances the cancer stem cell phenotype and increases chemotherapy resistance in Colorectal Cancer https://www.biorxiv.org/content/10.1101/2024.01.23.576664v1
BMP antagonist CHRDL2 enhances the cancer stem cell phenotype and increases chemotherapy resistance in Colorectal Cancer https://www.biorxiv.org/content/10.1101/2024.01.23.576664v1
Chordin-like-2 (CHRDL2) is a secreted BMP antagonist, with overexpression and genomic variants assoc
www.biorxiv.org
January 27, 2024 at 12:55 AM
biorxivpreprint.bsky.social
BMP antagonist CHRDL2 enhances the cancer stem cell phenotype and increases chemotherapy resistance in Colorectal Cancer https://www.biorxiv.org/content/10.1101/2024.01.23.576664v1
BMP antagonist CHRDL2 enhances the cancer stem cell phenotype and increases chemotherapy resistance in Colorectal Cancer https://www.biorxiv.org/content/10.1101/2024.01.23.576664v1
Chordin-like-2 (CHRDL2) is a secreted BMP antagonist, with overexpression and genomic variants assoc
www.biorxiv.org
January 27, 2024 at 12:55 AM